Weston Daniel

Company: EVOQ

Job title: Chief Development Officer

Seminars:

The NanoDisc Platform for Induction of Antigen- Specific Immune Tolerance 2:00 pm

Enabling disease-specific autoimmune therapy by lymph node and tolerogenic organ distribution Eliciting tolerizing dendritic cell signaling and bystander suppression Discussing applications to disease modelsRead more

day: Day 1 Treg Modulatorstrack

Industry Leader’s Fireside Chat: Comparing Treg Cell Therapies & Treg Modulators as Effective Treatments for Inflammatory & Autoimmune Diseases 8:30 am

Exploring the effectiveness of treatment personalization to direct the future of Treg therapies Discussing technological challenges in Treg cell therapy or Treg modulator development Comparing Treg cell therapy and modulator treatment efficacy to identify enhancements to progress Treg therapiesRead more

day: Conference Day One AM